Oral isotretinoin in the treatment and prevention of cutaneous squamous cell carcinoma.

The clinical uses of oral isotretinoin (13-cis-retinoic acid) are many. They include treatment of acneiform eruptions, diseases of cornification, inflammatory disorders, and neoplastic processes. Isotretinoin has shown greater efficacy in the chemoprevention of squamous cell carcinoma, rather than in the treatment. High-dose isotretinoin has mainly been utilized in those patients at high-risk for multiple new skin cancers where the risk of morbidity from side effects is overshadowed by the benefit to the patient.
AuthorsEvan Jones, Adam Korzenko, David Kriegel
JournalJournal of drugs in dermatology : JDD (J Drugs Dermatol) 2004 Sep-Oct Vol. 3 Issue 5 Pg. 498-502 ISSN: 1545-9616 [Print] United States
PMID15552602 (Publication Type: Journal Article, Review)
Chemical References
  • Isotretinoin
  • Administration, Oral
  • Carcinoma, Squamous Cell (drug therapy, prevention & control)
  • Humans
  • Isotretinoin (administration & dosage, adverse effects, therapeutic use)
  • Randomized Controlled Trials as Topic
  • Skin Neoplasms (drug therapy, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: